Quercetin: What the Blood Pressure and Allergy Trials Actually Show

By Erin Rose · Updated July 18, 2026 · Methodology

Educational overview — not medical advice. Quercetin is not a substitute for prescribed blood-pressure medication or antihistamines, and there is no long-term (12-week+) human safety data at high doses. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

As an Amazon Associate we earn from qualifying purchases. On best quercetin, products are ranked by form (plain vs phytosome, never pooled) and disclosed mg first, not commissions.

Start here

What quercetin is, and the two threads that hold up

Quercetin is a flavonoid found in onions, apples, berries, and other plants, sold as a supplement in two structurally different forms: plain (unformulated) quercetin dihydrate, and phytosome quercetin, a lecithin-bound delivery form (branded as Quercefit) engineered to absorb better. It is not an essential nutrient — there's no deficiency state, no RDA, and no government-set upper limit — so any benefit has to stand on its own trial evidence. Two threads run through the twelve verified trials and reviews in this evidence base. The strongest is blood pressure: three independent meta-analyses pooling dozens of RCTs each found a small, statistically significant systolic and diastolic reduction from plain quercetin, with the effect concentrated at doses of 500 mg/day and up and larger in people who already run hypertensive or pre-hypertensive — see the full breakdown. The second, thinner thread is allergic rhinitis: quercetin has real mast-cell-stabilizing activity, and one randomized trial of a branded phytosome (Yamada 2022, n=66 — a single small, industry-associated trial) found significant symptom improvement over four weeks — a real early signal, not proof of an antihistamine-replacement effect.

The absorption problem — the #1 buyer-relevant fact

Plain quercetin is poorly absorbed. A randomized crossover pharmacokinetic trial (Riva 2019, n=12) measured plasma quercetin after 500 mg of plain quercetin versus 250 mg or 500 mg of Quercetin Phytosome, and found the phytosome form reached plasma levels up to 20 times higher at the same labeled milligram amount. That single fact explains why the blood-pressure trials (which mostly used plain quercetin at 500–1000 mg/day) and the allergy trial (which used 200 mg/day of phytosome) land on such different-looking dose numbers — they are not the same dose delivered in a smaller pill, they are two different absorption curves. Every page in this cluster that states a dose specifies which form it means; see the dosage guide and the buying comparison for why this changes what "cost per mg" even means.

Safety, briefly

Adverse effects from supplemental quercetin are rarely reported and generally mild at doses tested up to about 1000 mg/day (Andres 2018). Two things worth knowing: a theoretical (animal-data-based) nephrotoxicity concern in people with pre-existing kidney impairment, and a real drug-interaction mechanism — quercetin can alter the metabolism of certain co-administered drugs, so check with a pharmacist if you take quinolone antibiotics, anticoagulants/blood thinners, or CYP450-metabolized medications. No long-term (12-week+) high-dose human safety data exists. Full detail on the dosage guide.

Frequently asked questions

Related guides

• Vitamin C — another antioxidant flavonoid-adjacent supplement with its own absorption questions
• Zinc — frequently paired with quercetin in multicomponent immune formulas
• Omega-3 — another supplement with real, modest, dose-dependent cardiovascular evidence
• NAC — the site's other antioxidant-adjacent supplement with a real-but-overstated marketing gap

Sources